2016
Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children
Kajubi R, Huang L, Were M, Kiconco S, Li F, Marzan F, Gingrich D, Nyunt MM, Ssebuliba J, Mwebaza N, Aweeka FT, Parikh S. Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children. Open Forum Infectious Diseases 2016, 3: ofw217. PMID: 28018925, PMCID: PMC5170492, DOI: 10.1093/ofid/ofw217.Peer-Reviewed Original ResearchParasite clearanceArtemether-lumefantrineDHA exposureUgandan childrenHuman immunodeficiency virus (HIV) infectionArtemether-lumefantrine treatmentDaily blood smearsEarly parasite clearanceInitial parasite clearanceImmunodeficiency virus infectionLopinavir/ritonavirHuman immunodeficiency virusParasite clearance ratesAL efficacyArtemisinin pharmacokineticsAntiretroviral therapyHIV statusImmunodeficiency virusPK exposureArtemisinin resistanceTreatment outcomesVirus infectionHIVPharmacokinetic parametersBlood smears
2011
Time to and Predictors of CD4+ T‐Lymphocytes Recovery in HIV‐Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana
Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E. Time to and Predictors of CD4+ T‐Lymphocytes Recovery in HIV‐Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana. AIDS Research And Treatment 2011, 2011: 896040. PMID: 21738861, PMCID: PMC3124224, DOI: 10.1155/2011/896040.Peer-Reviewed Original ResearchT-lymphocyte recoveryPredictors of CD4Resource-limited settingsHAART initiationKorle-Bu Teaching HospitalMost resource-limited settingsCox proportional hazards modelT-lymphocyte countsActive antiretroviral therapyMedian recovery timeProportional hazards modelPredictors of timeComplete CD4Percent CD4Antiretroviral therapyActive antiretroviralsMean ageTeaching hospitalT lymphocytesCD4Hazards modelHIVChildrenAgeSignificant predictor variables